Gloukoom: Verskil tussen weergawes
Content deleted Content added
Sien ook |
Dagga |
||
Lyn 42:
== Epidemiologie ==
Ongeveer 6 tot 67 miljoen mense het wêreldwyd gloukoom{{R|Man2015|GBD2015Pre}} en dit kom meer gereeld voor by ouer mense.{{R|NIH2016Fact}} Geslote-hoek gloukoom is meer algemeen by vroue.{{R|Man2015}} Gloukoom word die "stille dief van sig" genoem, omdat die sigverlies meestal oor 'n lang tyd stadig voorkom.{{R|NEI}} Gloukoom is wêreldwyd die tweede grootste oorsaak van blindheid na [[katarak]]te.{{R|Man2015|Resnikoff}} Katarakte het in 2010 51% van blindheid veroorsaak, terwyl gloukoom 8% veroorsaak het.{{R|WHO2010}}
== Dagga ==
Studies in die 1970's het gemeld dat die gebruik van cannabis die intraokulêre druk kan verlaag.{{R|Joy|AOA}} In 'n poging om vas te stel of dagga, of medisyne wat daaruit verkry is, effektief kan wees as 'n gloukoombehandeling, het die Amerikaanse Nasionale Ooginstituut navorsingstudies van 1978 tot 1984 gesteun. Hierdie studies het getoon dat sommige afgeleides van dagga intraokulêre druk kon verlaag wanneer dit mondelings, intraveneus toegedien word , of deur te rook, maar nie as dit topies op die oog toegedien word nie.
In 2003 het die Amerikaanse Akademie vir Oogheelkunde 'n standpuntverklaring vrygestel waarin verklaar word dat dagga nie meer effektief is as medisyne op voorskrif nie. Daar is ook geen wetenskaplike bewyse gevind wat verhoogde voordele en / of verminderde risiko's van daggagebruik toon vir die behandeling van gloukoom in vergelyking met die groot verskeidenheid farmaseutiese middels wat nou beskikbaar is nie.{{R|AOA}}
In 2010 het die American Glaucoma Society 'n standpuntdokument gepubliseer wat die gebruik van dagga as 'n wettige behandeling teen verhoogde intraokulêre druk diskrediteer, om redes insluitend die kort tydsduur van die werking en newe-effekte wat die daaglikse lewensaktiwiteite beperk.{{R|pmid20160576}}
== Sien ook ==
Line 48 ⟶ 55:
== Verwysings ==
{{verwysings|30em|verwysings=
<ref name="AOA">{{cite web |publisher=American Academy of Ophthalmology |url=http://one.aao.org/CE/PracticeGuidelines/Therapy_Content.aspx?cid=9871fa42-cf40-4c1f-b05c-c816d5f93126 |title=Complementary Therapy Assessment: Marijuana in the Treatment of Glaucoma |accessdate=4 Mei 2011 |language=Engels}}</ref>
<ref name="GBD2015Pre">{{cite journal|last1=GBD 2015 Disease and Injury Incidence and Prevalence|first1=Collaborators.|title=Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015|journal=Lancet|date=8 Oktober 2016|volume=388|issue=10053|pages=1545–1602|pmid=27733282|doi=10.1016/S0140-6736(16)31678-6|pmc=5055577|language=Engels}}</ref>
<ref name="Ferri">{{cite book|last1=Ferri|first1=Fred F.|title=Ferri's differential diagnosis : a practical guide to the differential diagnosis of symptoms, signs, and clinical disorders|date=2010|publisher=Elsevier/Mosby|location=Philadelphia, PA|isbn=978-0323076999|page=Chapter G|edition=2de| language=Engels}}</ref>
<ref name="Joy">{{Cite book |url=https://archive.org/details/marijuanamedicin0000unse |title=Marijuana and Medicine: Assessing the Science Base |publisher=Nap.edu |accessdate=20 February 2014 |doi=10.17226/6376 |pmid=25101425 |year=1999 |last1=Joy |first1=J. E. |last2=Watson Jr. |first2=S. J. |last3=Benson Jr. |first3=J. A. |isbn=978-0-309-07155-0 |url-access=registration |language=Engels}}</ref>
<ref name="Leffler">{{cite journal| year=2013| title=Evolution and impact of eye and vision terms in written English| last=Leffler| first=CT| coauthors=Schwartz, SG; Stackhouse, R; Davenport, B; Spetzler, K| url=http://oculistmd.wordpress.com/article/evolution-and-impact-of-eye-and-vision-terms-in-written-english/| journal=JAMA Ophthalmology| volume=131| issue=12| pages=1625–31| doi=10.1001/jamaophthalmol.2013.917| pmid=24337558| url-status=live| archiveurl=https://web.archive.org/web/20141223122215/http://oculistmd.wordpress.com/article/evolution-and-impact-of-eye-and-vision-terms-in-written-english/| archivedate=23 Desember 2014| language=Engels}}</ref>
Line 61 ⟶ 72:
<ref name="NIH2016Fact">{{cite web|title=Facts About Glaucoma|url=https://nei.nih.gov/health/glaucoma/glaucoma_facts|website=National Eye Institute|accessdate=7 Augustus 2020|url-status=live|archiveurl=https://web.archive.org/web/20160328122443/https://nei.nih.gov/health/glaucoma/glaucoma_facts|archivedate=28 Maart 2016| language=Engels}}</ref>
<ref name="pmid20160576">{{cite journal |vauthors = Jampel H |s2cid = 40362575 |title = American glaucoma society position statement: marijuana and the treatment of glaucoma |journal = J. Glaucoma |volume = 19 |issue = 2 |pages = 75–6 |date = February 2010 |pmid = 20160576 |doi = 10.1097/IJG.0b013e3181d12e39}}</ref>
<ref name="Resnikoff">{{cite journal| coauthors=Pascolini, Donatella; Etya'Ale, Daniel; Kocur, Ivo; Pararajasegaram, Ramachandra; Pokharel, Gopal P.; Mariotti, Silvio P.| year=2004| title=Global data on visual impairment in the year 2002| url=http://www.who.int/bulletin/volumes/82/11/resnikoff1104abstract| journal=Bulletin of the World Health Organization| volume=82| issue=11| pages=844–51| pmc=2623053| pmid=15640920| first=Serge| last=Resnikoff| doi=10.1590/S0042-96862004001100009| url-status=live| archiveurl=https://web.archive.org/web/20131212220654/http://www.who.int/bulletin/volumes/82/11/resnikoff1104abstract/| archivedate=12 Desember 2013| doi-broken-date=7 Junie 2020| accessdate=7 Augustus 2020| language=Engels}}</ref>
| |||